Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression
Amro Aboukameel(The Barbara Ann Karmanos Cancer Institute), Asfar S. Azmi(The Barbara Ann Karmanos Cancer Institute)
Cited by 17
Related Papers
Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal Transition
|Scientific Reports|2015|36
Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy
|Advances in Radiation Oncology|2022|20